Welcome to our dedicated page for Healthlynked news (Ticker: HLYK), a resource for investors and traders seeking the latest updates and insights on Healthlynked stock.
HealthLynked Corp. (HLYK) is a healthcare technology company whose news flow centers on AI-enabled care coordination, patient engagement, payer partnerships, and digital health innovation. The HLYK news page on Stock Titan aggregates press releases and market updates so readers can follow how the company advances its platform connecting patients, providers, payers, and researchers.
Recent announcements highlight HealthLynked’s focus on AI-driven healthcare tools, including its ARI AI healthcare guide and multilingual health assistant, as well as new patent filings in AI care management, universal patient identifiers, and secure medical record access. News items also cover initiatives to expand interoperability, telemedicine, and cloud-based medical record sharing that underpin the company’s patient-centric network.
Investors and healthcare professionals can track strategic partnerships and corporate developments, such as engagements with advisory firms to support capital markets strategy and potential uplisting, collaborations with payer-focused organizations to accelerate value-based care, and the addition of experienced insurance and benefits executives to the board and management team. These updates provide insight into HealthLynked’s efforts to deepen relationships with insurers, employer groups, ACOs, and enterprise partners.
Operational news includes the launch of an upgraded MedOfficeDirect e-commerce platform for medical and dental supplies, enhancements to the enterprise solutions website, and improvements to the national provider directory. Together, these stories illustrate how HealthLynked is evolving its technology, expanding its ecosystem, and pursuing research partnerships that leverage its patient network and AI capabilities. Bookmark this page to follow earnings-related disclosures, platform launches, strategic agreements, and regulatory filings that shape the ongoing narrative around HLYK.
HealthLynked Corp. (OTCQB: HLYK) has welcomed Paul J. Norman to its advisory board. Norman, a former CEO and founder of NU Holdings Inc., brings extensive experience from the insurance sector, having been instrumental in establishing a network of over 3,000 independent agents. His induction into the Insurance Hall of Fame underscores his industry credibility. HealthLynked aims to enhance healthcare management through a cloud-based platform, connecting patients and providers efficiently. This addition to the advisory board is expected to bolster the company’s strategic direction in healthcare technology.
HealthLynked Corp. (OTCQB:HLYK) reported a 98% increase in Q3 2021 revenue, reaching $4.0 million compared to $2.0 million in Q3 2020. Patient appointments rose 24% to 4,181, while Time of Service collections grew 33% to $1.0 million. The company also received $2.4 million in Medicare Shared Savings revenue, a 213% increase year-over-year. Year-to-date revenue increased 66% to $7.5 million. Executives expressed optimism about ongoing growth and improvements in the financial performance.
HealthLynked Corp. (OTCQB:HLYK) announced that its subsidiary, ACO Health Partners LLC, will receive $2.4 million in Medicare Shared Savings from the Centers for Medicare & Medicaid Services (CMS). This amount marks a 213% increase from the $768,000 received last year. Since acquiring ACO Health Partners in May 2020, HealthLynked has reported substantial growth in shared savings and the number of attributed Medicare lives.
HealthLynked Corp. (OTCQB: HLYK) announced the launch of its new podcast channel across iTunes, Google, and Spotify on September 17, 2020. The initiative aims to enhance online medical education for patients and healthcare providers, responding to the surging popularity of podcasts. CEO Dr. Michael Dent emphasized the commitment to provide valuable audio content alongside existing video resources. The podcast will feature healthcare topics to engage a wide audience, contributing to HealthLynked's mission of improving healthcare through better information exchange.
HealthLynked Corp. (OTCQB: HLYK) has announced the completion of its data integration with athenahealth, enabling patients to easily access their medical records. This integration utilizes athenahealth's API, allowing patients to request their health data and verify their identity through HealthLynked's practice portal. With access to critical health information such as medications and lab results, this partnership aims to improve patient care and reduce delays in treatment. Patients will incur a small fee for each record request, while practices can onboard swiftly through athenahealth's marketplace.
HealthLynked Corp. (OTCQB: HLYK) announced on September 8, 2020, the retirement of three convertible notes amounting to $588,453. This strategic move eliminates the potential for market conversion of these shares and is viewed as a prudent use of funds from Dr. Dent's recent equity investment. CFO George O'Leary emphasized that this strengthens the balance sheet, reduces dilution, and positions the company favorably for future announcements.
HealthLynked Corp. (OTCQB: HLYK) announced a $3,000,000 equity investment from its Chairman and CEO, Dr. Michael Dent, reflecting his confidence in the company's future. Over the past year, HealthLynked has achieved significant milestones, including a 49% revenue increase compared to the same period in 2019, despite COVID-19's impact. Key initiatives included the launch of Cost Lynk, a COVID-19 tracker app, and the acquisition of Cura Health Management. This investment aims to support plans for a NASDAQ up-listing and enhance financial stability.
HealthLynked Corp. (OTCQB: HLYK) reported a 49% increase in revenue for the first half of 2020, totaling $2,498,450, alongside a 23% reduction in operating loss to $1,177,652. Second-quarter revenue dipped by 4% compared to 2019, while operating loss decreased by 7%. The company acquired Cura Health Management on May 18, 2020, aiming to enhance its ACO market presence. Telemedicine usage helped mitigate financial downturns during the COVID-19 pandemic, with patient revenue down only 4%.